share_log

オンコリスバイオファーマ:食道がん及び胃食道接合部がんへのテロメライシン(OBP-301)と化学放射線併用療法Phase1試験に関する最終症例組入れ完了のお知らせ

Oncolys BioPharma: Announcements of individual stocks: Completion of final case inclusion in Phase 1 trial of telomelysin (OBP-301) and chemoradiotherapy for esophageal and gastroesophageal junction cancer.

JPX ·  Aug 6 02:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more